Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats

A. C. Maritim, R. A. Sanders, J. B. Watkins

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

Increased oxidative stress and impaired antioxidant defense mechanisms are important factors in the pathogenesis and progression of diabetes mellitus and other oxidant-related diseases. This study was designed to determine whether α-lipoic acid, which has been shown to have substantial antioxidant properties, when administered (10 mg/kg ip) once daily for 14 days to normal and diabetic female Sprague-Dawley rats would prevent diabetes-induced changes in biomarkers of oxidative stress in liver, kidney and heart. Serum glucose concentrations, aspartate aminotransferase activity, and glycated hemoglobin levels, which were increased in diabetes, were not significantly altered by α-lipoic acid treatment. Normal rats treated with a high dose of α-lipoic acid (50 mg/kg) survived but diabetic rats on similar treatment died during the course of the experiment. The activity of glutathione peroxidase was increased in livers of normal rats treated with α-lipoic acid, but decreased in diabetic rats after α-lipoic acid treatment. Hepatic catalase activity was decreased in both normal and diabetic rats after α-lipoic acid treatment. Concentrations of reduced glutathione and glutathione disulfide in liver were increased after α-lipoic acid treatment of normal rats, but were not altered in diabetics. In kidney, glutathione peroxidase activity was elevated in diabetic rats, and in both normal and diabetic animals after α-lipoic acid treatment. Superoxide dismutase activity in heart was decreased in diabetic rats but normalized after treatment with α-lipoic acid; other cardiac enzyme activities were not influenced by either diabetes or antioxidant treatment. These results suggest that after 14 days of treatment with an appropriate pharmacological dose, α-lipoic acid may reduce oxidative stress in STZ-induced diabetic rats, perhaps by modulating the thiol status of the cells.

Original languageEnglish
Pages (from-to)288-294
Number of pages7
JournalJournal of Nutritional Biochemistry
Volume14
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Thioctic Acid
Oxidative stress
Biomarkers
Streptozocin
Rats
Oxidative Stress
Medical problems
Liver
Antioxidants
Glutathione Peroxidase
Kidney
Glutathione Disulfide
Glycosylated Hemoglobin A
Enzyme activity
Aspartate Aminotransferases
Sulfhydryl Compounds
Oxidants
Catalase
Superoxide Dismutase
Glutathione

Keywords

  • Alpha-lipoic acid
  • Antioxidant
  • Diabetes
  • Oxidative Stress
  • Rat
  • Streptozotocin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. / Maritim, A. C.; Sanders, R. A.; Watkins, J. B.

In: Journal of Nutritional Biochemistry, Vol. 14, No. 5, 01.05.2003, p. 288-294.

Research output: Contribution to journalArticle

Maritim, A. C. ; Sanders, R. A. ; Watkins, J. B. / Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. In: Journal of Nutritional Biochemistry. 2003 ; Vol. 14, No. 5. pp. 288-294.
@article{2490f9fe89a5433bbb41ff6a1887c816,
title = "Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats",
abstract = "Increased oxidative stress and impaired antioxidant defense mechanisms are important factors in the pathogenesis and progression of diabetes mellitus and other oxidant-related diseases. This study was designed to determine whether α-lipoic acid, which has been shown to have substantial antioxidant properties, when administered (10 mg/kg ip) once daily for 14 days to normal and diabetic female Sprague-Dawley rats would prevent diabetes-induced changes in biomarkers of oxidative stress in liver, kidney and heart. Serum glucose concentrations, aspartate aminotransferase activity, and glycated hemoglobin levels, which were increased in diabetes, were not significantly altered by α-lipoic acid treatment. Normal rats treated with a high dose of α-lipoic acid (50 mg/kg) survived but diabetic rats on similar treatment died during the course of the experiment. The activity of glutathione peroxidase was increased in livers of normal rats treated with α-lipoic acid, but decreased in diabetic rats after α-lipoic acid treatment. Hepatic catalase activity was decreased in both normal and diabetic rats after α-lipoic acid treatment. Concentrations of reduced glutathione and glutathione disulfide in liver were increased after α-lipoic acid treatment of normal rats, but were not altered in diabetics. In kidney, glutathione peroxidase activity was elevated in diabetic rats, and in both normal and diabetic animals after α-lipoic acid treatment. Superoxide dismutase activity in heart was decreased in diabetic rats but normalized after treatment with α-lipoic acid; other cardiac enzyme activities were not influenced by either diabetes or antioxidant treatment. These results suggest that after 14 days of treatment with an appropriate pharmacological dose, α-lipoic acid may reduce oxidative stress in STZ-induced diabetic rats, perhaps by modulating the thiol status of the cells.",
keywords = "Alpha-lipoic acid, Antioxidant, Diabetes, Oxidative Stress, Rat, Streptozotocin",
author = "Maritim, {A. C.} and Sanders, {R. A.} and Watkins, {J. B.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1016/S0955-2863(03)00036-6",
language = "English",
volume = "14",
pages = "288--294",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats

AU - Maritim, A. C.

AU - Sanders, R. A.

AU - Watkins, J. B.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Increased oxidative stress and impaired antioxidant defense mechanisms are important factors in the pathogenesis and progression of diabetes mellitus and other oxidant-related diseases. This study was designed to determine whether α-lipoic acid, which has been shown to have substantial antioxidant properties, when administered (10 mg/kg ip) once daily for 14 days to normal and diabetic female Sprague-Dawley rats would prevent diabetes-induced changes in biomarkers of oxidative stress in liver, kidney and heart. Serum glucose concentrations, aspartate aminotransferase activity, and glycated hemoglobin levels, which were increased in diabetes, were not significantly altered by α-lipoic acid treatment. Normal rats treated with a high dose of α-lipoic acid (50 mg/kg) survived but diabetic rats on similar treatment died during the course of the experiment. The activity of glutathione peroxidase was increased in livers of normal rats treated with α-lipoic acid, but decreased in diabetic rats after α-lipoic acid treatment. Hepatic catalase activity was decreased in both normal and diabetic rats after α-lipoic acid treatment. Concentrations of reduced glutathione and glutathione disulfide in liver were increased after α-lipoic acid treatment of normal rats, but were not altered in diabetics. In kidney, glutathione peroxidase activity was elevated in diabetic rats, and in both normal and diabetic animals after α-lipoic acid treatment. Superoxide dismutase activity in heart was decreased in diabetic rats but normalized after treatment with α-lipoic acid; other cardiac enzyme activities were not influenced by either diabetes or antioxidant treatment. These results suggest that after 14 days of treatment with an appropriate pharmacological dose, α-lipoic acid may reduce oxidative stress in STZ-induced diabetic rats, perhaps by modulating the thiol status of the cells.

AB - Increased oxidative stress and impaired antioxidant defense mechanisms are important factors in the pathogenesis and progression of diabetes mellitus and other oxidant-related diseases. This study was designed to determine whether α-lipoic acid, which has been shown to have substantial antioxidant properties, when administered (10 mg/kg ip) once daily for 14 days to normal and diabetic female Sprague-Dawley rats would prevent diabetes-induced changes in biomarkers of oxidative stress in liver, kidney and heart. Serum glucose concentrations, aspartate aminotransferase activity, and glycated hemoglobin levels, which were increased in diabetes, were not significantly altered by α-lipoic acid treatment. Normal rats treated with a high dose of α-lipoic acid (50 mg/kg) survived but diabetic rats on similar treatment died during the course of the experiment. The activity of glutathione peroxidase was increased in livers of normal rats treated with α-lipoic acid, but decreased in diabetic rats after α-lipoic acid treatment. Hepatic catalase activity was decreased in both normal and diabetic rats after α-lipoic acid treatment. Concentrations of reduced glutathione and glutathione disulfide in liver were increased after α-lipoic acid treatment of normal rats, but were not altered in diabetics. In kidney, glutathione peroxidase activity was elevated in diabetic rats, and in both normal and diabetic animals after α-lipoic acid treatment. Superoxide dismutase activity in heart was decreased in diabetic rats but normalized after treatment with α-lipoic acid; other cardiac enzyme activities were not influenced by either diabetes or antioxidant treatment. These results suggest that after 14 days of treatment with an appropriate pharmacological dose, α-lipoic acid may reduce oxidative stress in STZ-induced diabetic rats, perhaps by modulating the thiol status of the cells.

KW - Alpha-lipoic acid

KW - Antioxidant

KW - Diabetes

KW - Oxidative Stress

KW - Rat

KW - Streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=0037707713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037707713&partnerID=8YFLogxK

U2 - 10.1016/S0955-2863(03)00036-6

DO - 10.1016/S0955-2863(03)00036-6

M3 - Article

VL - 14

SP - 288

EP - 294

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 5

ER -